Rachman, J <br/><br/>
Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.  [electronic resource] 

 -  Diabetes  Oct 1997 
 - 1557-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0012-1797 
<br/><br/><label>Standard No.: </label>10.2337/diacare.46.10.1557  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Arginine<br/>Blood Glucose--metabolism<br/>C-Peptide--blood<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--blood<br/>Fasting<br/>Gliclazide--therapeutic use<br/>Glucose Clamp Technique<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Middle Aged<br/>Proinsulin--blood